Binance Square

vaccineswork

5,230 views
4 Discussing
GALAXY 7
--
🚨🚨 BREAKING NEWS 🚨🚨 Russia announces cancer vaccine is ready for use, free for all patients. Russia’s Enteromix Cancer Vaccine Completes Pre-Clinical Trials, Awaits Approval Russia’s Federal Medical and Biological Agency (FMBA) has announced that its new mRNA cancer vaccine, Enteromix, has successfully passed preclinical trials and is now considered "ready for use," pending regulatory approval. The announcement was made by FMBA chief Veronika Skvortsova during the Eastern Economic Forum held in Vladivostok. According to Skvortsova, the research spanned several years—of which the last three were dedicated to essential preclinical studies. These studies confirmed the vaccine’s safety, even with repeated administration, and demonstrated significant efficacy. Tumor reduction and slowed cancer progression—ranging between 60% to 80%—were observed across test models, alongside improved survival outcomes. Enteromix primarily targets colorectal cancer initially, though development efforts are advancing for vaccines against glioblastoma and certain forms of melanoma (including ocular melanoma). The development and announcement took place amid the 10th Eastern Economic Forum (September 3–6, 2025), which drew over 8,400 participants from more than 75 countries under the slogan “The Far East: Cooperation for Peace and Prosperity.” FOR APPRECIATION : follow , like, share thank you . #VaccinesWork #cancer #Technology #CancerResearch #MedicalBreakthrough
🚨🚨 BREAKING NEWS 🚨🚨 Russia announces cancer vaccine is ready for use, free for all patients.

Russia’s Enteromix Cancer Vaccine Completes Pre-Clinical Trials, Awaits Approval

Russia’s Federal Medical and Biological Agency (FMBA) has announced that its new mRNA cancer vaccine, Enteromix, has successfully passed preclinical trials and is now considered "ready for use," pending regulatory approval. The announcement was made by FMBA chief Veronika Skvortsova during the Eastern Economic Forum held in Vladivostok.

According to Skvortsova, the research spanned several years—of which the last three were dedicated to essential preclinical studies. These studies confirmed the vaccine’s safety, even with repeated administration, and demonstrated significant efficacy. Tumor reduction and slowed cancer progression—ranging between 60% to 80%—were observed across test models, alongside improved survival outcomes.

Enteromix primarily targets colorectal cancer initially, though development efforts are advancing for vaccines against glioblastoma and certain forms of melanoma (including ocular melanoma).

The development and announcement took place amid the 10th Eastern Economic Forum (September 3–6, 2025), which drew over 8,400 participants from more than 75 countries under the slogan “The Far East: Cooperation for Peace and Prosperity.”

FOR APPRECIATION : follow , like, share thank you .

#VaccinesWork
#cancer
#Technology
#CancerResearch
#MedicalBreakthrough
Justfortoday_48:
Também estou convencido
A massive study of nearly 46 million adults in England confirms that getting vaccinated against COVID‑19 is linked with fewer heart attacks and strokes in the weeks following each shot—with drops of up to 10–27% compared to unvaccinated individuals This adds to growing evidence showing vaccines also reduce serious heart failure and dangerous blood clots post-COVID infection—even up to a year later Great news for heart health and public safety! #HealthNews #HeartHealth #VaccinesWork #COVID19 #PublicHealth #StayProtected
A massive study of nearly 46 million adults in England confirms that getting vaccinated against COVID‑19 is linked with fewer heart attacks and strokes in the weeks following each shot—with drops of up to 10–27% compared to unvaccinated individuals

This adds to growing evidence showing vaccines also reduce serious heart failure and dangerous blood clots post-COVID infection—even up to a year later
Great news for heart health and public safety!

#HealthNews #HeartHealth #VaccinesWork #COVID19 #PublicHealth #StayProtected
A massive study of nearly 46 million adults in England confirms that getting vaccinated against COVID‑19 is linked with fewer heart attacks and strokes in the weeks following each shot—with drops of up to 10–27% compared to unvaccinated individuals This adds to growing evidence showing vaccines also reduce serious heart failure and dangerous blood clots post-COVID infection—even up to a year later Great news for heart health and public safety! #HealthNews #HeartHealth #VaccinesWork
A massive study of nearly 46 million adults in England confirms that getting vaccinated against COVID‑19 is linked with fewer heart attacks and strokes in the weeks following each shot—with drops of up to 10–27% compared to unvaccinated individuals
This adds to growing evidence showing vaccines also reduce serious heart failure and dangerous blood clots post-COVID infection—even up to a year later
Great news for heart health and public safety!

#HealthNews #HeartHealth #VaccinesWork
Login to explore more contents
Explore the latest crypto news
⚡️ Be a part of the latests discussions in crypto
💬 Interact with your favorite creators
👍 Enjoy content that interests you
Email / Phone number